3.0
Jun 5, 2021
Recommend
CEO approval
Business Outlook
Pros
Good pharma experience with account selling opportunities
Cons
Same as all larger pharma with less name recognition. Went though a “good old boy” phase a few years back. Leadership may have grown out of this.